BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Dr. Rana McKay
But that's sort of the spectrum, I think, across the way, the intensity and the potency and the duration is really largely been driven by the risk, the patient risk factors.
0
💬
0
Comments
Log in to comment.
There are no comments yet.